Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Early Lessons from the COVID-19 Pandemic: A Q&A with Chris Phillips, MD

Kurt Ullman  |  December 7, 2020

TR: What have been your patients’ concerns about the effects of immunosuppressant medications during this pandemic?
Dr. Phillips: My patients have been all over the spectrum. Early in the pandemic, we messaged patients they shouldn’t stop treatment, and we wanted to talk to them about their concerns. As COVID-19 has progressed, we’ve gotten data from the COVID-19 Global Rheumatology Alliance about rheumatic patients who have contracted COVID-19. The data have been reassuring suggesting prednisone above 10 mg is a risk factor for complications, but the other drugs we use seem to not have increased complication risks. Speaking for myself, that data have given me a reasonable comfort level.

TR: What are you telling your patients about a possible COVID-19 vaccine, and are you using the ACR vaccine guideline/COVID-19-related guidance?
Dr. Phillips: We are in the process of rolling out that literature in our office. My messaging is following closely what is in the document. I’m focusing on vaccines being generally safe.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The conversation I have been having with my patients is that they—and myself—should be prepared to get the vaccine at some point. For the vast majority of people, the risk to benefit [profile] is going to [favor] taking the vaccine. It’s hard to give firm guidance when we don’t know which vaccine(s) will be available.

TR: What is next for your practice?
Dr. Phillips: The biggest point for me is I don’t think we can begin talking about recovery from COVID-19 right now. The first battle is over, but the next one is yet to come. I’m anxious about how winter is going to go. I am hopeful that those of us who got through the initial storm—physically and financially—are equally successful in weathering the second storm.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We have learned to be much more flexible. Over the next few months, we can’t assume anything about what the environment will look like. We have to be super flexible. We can’t assume things are fine and will continue to go that way, so that our bank accounts will stay full, and we will stay healthy. We can no longer take any of these things for granted.


Kurt Ullman is a freelance writer based in Indiana.

Page: 1 2 | Single Page
Share: 

Filed under:Professional Topics Tagged with:COVID-19telemedicine

Related Articles

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

    Dr. Chris Phillips Competes in Triathlons

    October 18, 2018

    “I think I’m mentally sharper when I have been exercising and taking care of myself,” says Chris Phillips, MD, a rheumatologist in solo practice in Paducah, Ky. Dr. Phillips has recognized these benefits since high school, when he began participating in competitive sports. Four years ago, Dr. Phillips was competing against 40 other cyclists in…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences